Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

DDW Cell and Gene Therapy Showcase

Join us for the 2024 DDW Cell & Gene Therapy Showcase, a free online event hosted by DDW and co-sponsored by Benchling, Sartorius, Applied StemCell, and Elegen Bio.

In this free online event, leading industry figures will outline areas of opportunity in CGT drug discovery & development sector as well as highlighting challenges facing the industry and how they can be overcome. It will feature presentations from experts in the field of cell and gene therapy drug development as well as a panel discussion.

Presentations will cover areas such as the complexities of an unclear and rapidly evolving regulatory framework for cell and gene therapies, offering examples of how to navigate the investigational new drug (IND) submission process. They will also cover how next-generation gene synthesis technology is helping to advance areas such as TCR engineering, CAR-T therapies, gene editing, and mRNA vaccines. In addition, sponsors will be given the opportunity to present their technology to the DDW audience.

Register now to Watch